MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$44,648K
(-102.12%↓ Y/Y)
Net loss
-$44,162K
(-95.10%↓ Y/Y)
Total other
comprehensive (gain) income
-$486K
(-189.01%↓ Y/Y)
Income tax recovery
(expense)
-$2,191K
(-541.73%↓ Y/Y)
Interest income
$2,711K
(-20.82%↓ Y/Y)
Other income, net
$120K
(144.90%↑ Y/Y)
Loss before income
taxes
-$46,353K
(-109.36%↓ Y/Y)
Unrealized (gain) income on
available for sale...
-$486K
(-189.01%↓ Y/Y)
Total other income,
net
$765K
(-77.97%↓ Y/Y)
Jazz-Royalty
$1,330K
(558.42%↑ Y/Y)
Jazz-Research Support
Payments And Other...
$392K
(-91.28%↓ Y/Y)
Drug Supply For
Ongoing Studies-Jazz
$345K
(-88.33%↓ Y/Y)
Be One Medicines
Ltd.-Royalty
$224K
Drug Supply-Jazz
$117K
(-94.56%↓ Y/Y)
Interest expense related
to sale of future...
$2,066K
Loss from operations
-$47,118K
(-83.96%↓ Y/Y)
Research and development
collaborations
$2,408K
(-91.12%↓ Y/Y)
Total operating
expenses
$49,526K
(-6.06%↓ Y/Y)
Research and development
$34,457K
(-3.58%↓ Y/Y)
General and
administrative
$15,069K
(-11.28%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)